This webinar provides an overview of a new resource available through the Pacific Southwest Addiction Technology Transfer Center named ‘Treatment for Individuals who Use Stimulants (TRUST)’, a protocol using empirically-supported behavioral treatments for people with stimulant use disorders.
Although over 46 million people reside in rural areas, around 80% of rural America is still classified as medically underserved.
October is Prevention Month! We’re observing Youth Substance Use Prevention Month and Substance Misuse Prevention Month.
The art of effective social media marketing and outreach requires organizations to be adept at creating targeted content that speaks to the right person, in the right way, at the right time.
This document provides information on xylazine, a non-opioid veterinary tranquilizer used as an additive in illicit drug supplies, notably in combination with heroin and fentanyl.
A Focus on Stimulants: Stimulant Treatment Considerations for Specific Populations in Rural Communities.
This webinar provides an overview of the fentanyl crisis impacting non-metropolitan rural communities, and the emerging issue of xylazine. While xylazine is not believed to be widespread in rural communities, providers working in rural settings need to be prepared for this emerging issue and how it complicates the response to opioid overdose
This webinar provides an overview on the impact of stimulant use on non-metropolitan rural communities.
Results from the 2021 and 2022 National Surveys on Drug Use and Health, indicating that lesbian, gay, and bisexual adults are more likely than straight adults to use substances, experience mental health conditions including major depressive episodes, and experience serious thoughts of suicide.
The Impact of Opioid Use on Rural Communities and Effective Treatment Approaches and Recovery Supports